Edition:
United States

Nate Raymond

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

Jul 21 2017

WilmerHale must face shareholder 'freeze-out' suit: Massachusetts court

A Massachusetts appeals court on Friday revived a lawsuit by the minority shareholders of a Boston-based company seeking to hold WilmerHale and another law firm liable for their role in a "freeze-out" they say the company's majority owner orchestrated.

Jul 21 2017

FBI seizes records tied to Insys-paid doctor in Kansas

The FBI last week executed a search warrant at a Kansas medical group formerly owned by a physician who received thousands of dollars in speaker fees from Insys Therapeutics Inc, a drug company at the center of a federal kickback probe.

Jul 21 2017

U.S. jury sides with Amphastar over Momenta in drug patent trial

BOSTON A federal jury handed Amphastar Pharmaceuticals Inc a big win on Friday after it was accused of infringing on a patent held by Momenta Pharmaceuticals Inc through its production of a generic version of the blood-thinner Lovenox.

Jul 21 2017

U.S. jury sides with Amphastar over Momenta in drug patent trial

BOSTON A federal jury handed Amphastar Pharmaceuticals Inc a big win on Friday after it was accused of infringing on a patent held by Momenta Pharmaceuticals Inc through its production of a generic version of the blood-thinner Lovenox.

Jul 20 2017

AbbVie loses bid to overturn $15 million Depakote injury verdict

A federal judge has rejected AbbVie Inc's bid to overturn a $15 million verdict for a 10-year-old boy whose mother blamed his birth defect on its bipolar disorder drug Depakote, which she took while she was pregnant.

Jul 20 2017

Momenta seeks $938 million from Amphastar at drug patent trial's end

A lawyer for Momenta Pharmaceuticals Inc urged a federal jury on Thursday to force Amphastar Pharmaceuticals Inc to pay $938 million for infringing a patent the drugmaker held through its production of a generic version of the blood-thinner Lovenox.

Jul 20 2017

Ex-Ariad employee's husband charged with insider trading

BOSTON The operator of a Massachusetts-based medical marijuana consultation practice was arrested on Thursday on charges that he engaged in insider trading based on information he learned from his wife, a former employee of Ariad Pharmaceuticals Inc.

Jul 20 2017

Ex-Ariad employee's husband charged with insider trading

BOSTON The operator of a Massachusetts-based medical marijuana consultation practice was arrested on Thursday on charges that he engaged in insider trading based on information he learned from his wife, a former employee of Ariad Pharmaceuticals Inc.

Jul 20 2017

Ex-Akebia employee faces losing bail in insider trading case

BOSTON A former Akebia Therapeutics Inc employee accused of insider trading faced the growing possibility of having his bail revoked as a U.S. prosecutor argued on Thursday that he posed a flight risk and was growing "increasingly unhinged."

Jul 20 2017

Ex-Akebia employee faces losing bail in insider trading case

BOSTON A former Akebia Therapeutics Inc employee accused of insider trading faced the growing possibility of having his bail revoked as a U.S. prosecutor argued on Thursday that he posed a flight risk and was growing "increasingly unhinged."

Markets

  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary